Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Genprex Inc
GNPX | US
1.02
USD0
0%
GNPX | US
Loading StockChartView...
About Genprex Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
1.02
Open
1.02
High
1.02
Low
0.96
Genprex Inc. a clinical-stage gene therapy company focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes and GPX-003 for the treatment of type 2 diabetes. Genprex Inc. was incorporated in 2009 and is headquartered in Austin Texas.
View LessGNPX | US
Risk
79.9
Sharpe
-0.35
Luna's Score
36/100
Recommendation
Sell
Luna says (GNPX | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
93.8%1 month
79.9%3 months
102.2%6 months
121.5%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.25
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
0.18
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-26.28M
MarketCap
2.64M
MarketCap(USD)
2.64M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-318.88
Short ratio
0.09
Short perc.
3.16
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.39
Range1M
1.01
Range3M
2.15
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.61
Price X volume
668.66K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.18 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.25 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 102.24 | 72.80 | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 2.64M | 3.66B | Emerging |
